Initial observation or treatment for diabetic macular oedema with good visual acuity: two-year outcomes comparison in routine clinical practice: data from the Fight Retinal Blindness! Registry Save Sight Registries Initial observation or treatment for diabetic macular oedema with good visual acuity: two-year outcomes comparison in routine clinical practice: data from the Fight Retinal Blindness! Registry Read More »
Quality of life impact of eye diseases: a Save Sight Registries study Save Sight Registries Quality of life impact of eye diseases: a Save Sight Registries study Read More »
Creation of a neovascular age-related macular degeneration national database using a web-based platform: Fight Retinal Blindness Spain. Report 1: Visual outcomes Save Sight Registries Creation of a neovascular age-related macular degeneration national database using a web-based platform: Fight Retinal Blindness Spain. Report 1: Visual outcomes Read More »
Comparative study of 2-year outcomes for Hydrus or iStent inject microinvasive glaucoma surgery implants with cataract surgery Save Sight Registries Comparative study of 2-year outcomes for Hydrus or iStent inject microinvasive glaucoma surgery implants with cataract surgery Read More »
International impact of the COVID-19 pandemic lockdown on intravitreal therapy outcomes: Fight Retinal Blindness registry Save Sight Registries International impact of the COVID-19 pandemic lockdown on intravitreal therapy outcomes: Fight Retinal Blindness registry Read More »
Dexamethasone Implant for Diabetic Macular Oedema: 1-Year Treatment Outcomes from the Fight Retinal Blindness! Registry Save Sight Registries Dexamethasone Implant for Diabetic Macular Oedema: 1-Year Treatment Outcomes from the Fight Retinal Blindness! Registry Read More »
Bevacizumab for diabetic macular oedema: one-year treatment outcomes from the Fight Retinal Blindness! Registry Save Sight Registries Bevacizumab for diabetic macular oedema: one-year treatment outcomes from the Fight Retinal Blindness! Registry Read More »
Vascular endothelial growth factor inhibitors for predominantly Caucasian myopic choroidal neovascularization: 2-year treatment outcomes in clinical practice: data from the Fight Retinal Blindness! Registry Save Sight Registries Vascular endothelial growth factor inhibitors for predominantly Caucasian myopic choroidal neovascularization: 2-year treatment outcomes in clinical practice: data from the Fight Retinal Blindness! Registry Read More »
The impact of disease activity on 5-year outcomes in patients undergoing treatment for neovascular age-related macular degeneration Save Sight Registries The impact of disease activity on 5-year outcomes in patients undergoing treatment for neovascular age-related macular degeneration Read More »
The Save Sight Keratoconus Registry – Optometry Module: an opportunity to use real-world data to advance eye care Save Sight Registries The Save Sight Keratoconus Registry – Optometry Module: an opportunity to use real-world data to advance eye care Read More »
Comparative Efficacy and Safety of Standard Versus Accelerated Corneal Crosslinking for Keratoconus: 1-Year Outcomes From the Save Sight Keratoconus Registry Study Save Sight Registries Comparative Efficacy and Safety of Standard Versus Accelerated Corneal Crosslinking for Keratoconus: 1-Year Outcomes From the Save Sight Keratoconus Registry Study Read More »
Efficient capture of high-quality real-world data on treatments for glaucoma: the Fight Glaucoma Blindness! Registry Save Sight Registries Efficient capture of high-quality real-world data on treatments for glaucoma: the Fight Glaucoma Blindness! Registry Read More »